Nectar Lifesciences informs about press release

08 Jul 2025 Evaluate

Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Nectar Lifesciences has informed that it enclosed a Press Release issued by the Company titled ‘Nectar Lifesciences Announces Strategic Sale of API and Formulations Business to Ceph Lifesciences for ?1,270 Crores’.

The above information is a part of company’s filings submitted to BSE.

Nectar Lifesciences Share Price

20.95 0.01 (0.05%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×